Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 22

1.

NIR-II fluorescence imaging using indocyanine green nanoparticles.

Bhavane R, Starosolski Z, Stupin I, Ghaghada KB, Annapragada A.

Sci Rep. 2018 Sep 27;8(1):14455. doi: 10.1038/s41598-018-32754-y.

2.

Indocyanine green fluorescence in second near-infrared (NIR-II) window.

Starosolski Z, Bhavane R, Ghaghada KB, Vasudevan SA, Kaay A, Annapragada A.

PLoS One. 2017 Nov 9;12(11):e0187563. doi: 10.1371/journal.pone.0187563. eCollection 2017.

3.

Pre-clinical evaluation of a nanoparticle-based blood-pool contrast agent for MR imaging of the placenta.

Ghaghada KB, Starosolski ZA, Bhayana S, Stupin I, Patel CV, Bhavane RC, Gao H, Bednov A, Yallampalli C, Belfort M, George V, Annapragada AV.

Placenta. 2017 Sep;57:60-70. doi: 10.1016/j.placenta.2017.06.008. Epub 2017 Jun 15.

PMID:
28864020
4.

Corrigendum: A liposomal Gd contrast agent does not cross the mouse placental barrier.

Shetty AN, Pautler R, Ghaghada K, Rendon D, Gao H, Starosolski Z, Bhavane R, Patel C, Annapragada A, Yallampalli C, Lee W.

Sci Rep. 2017 Feb 16;7:39724. doi: 10.1038/srep39724. No abstract available.

5.

Multimodal Magnetic Resonance and Near-Infrared-Fluorescent Imaging of Intraperitoneal Ovarian Cancer Using a Dual-Mode-Dual-Gadolinium Liposomal Contrast Agent.

Ravoori MK, Singh S, Bhavane R, Sood AK, Anvari B, Bankson J, Annapragada A, Kundra V.

Sci Rep. 2016 Dec 22;6:38991. doi: 10.1038/srep38991.

6.

A liposomal Gd contrast agent does not cross the mouse placental barrier.

Shetty AN, Pautler R, Ghaghada K, Rendon D, Gao H, Starosolski Z, Bhavane R, Patel C, Annapragada A, Yallampalli C, Lee W.

Sci Rep. 2016 Jun 14;6:27863. doi: 10.1038/srep27863. Erratum in: Sci Rep. 2017 Feb 16;7:39724.

7.

Multistage Nanovectors Enhance the Delivery of Free and Encapsulated Drugs.

Martinez JO, Evangelopoulos M, Bhavane R, Acciardo S, Salvatore F, Liu X, Ferrari M, Tasciotti E.

Curr Drug Targets. 2015;16(14):1582-90.

8.

Dual-energy computed tomography imaging of atherosclerotic plaques in a mouse model using a liposomal-iodine nanoparticle contrast agent.

Bhavane R, Badea C, Ghaghada KB, Clark D, Vela D, Moturu A, Annapragada A, Johnson GA, Willerson JT, Annapragada A.

Circ Cardiovasc Imaging. 2013 Mar 1;6(2):285-94. doi: 10.1161/CIRCIMAGING.112.000119. Epub 2013 Jan 24.

9.

Intravenous delivery of targeted liposomes to amyloid-β pathology in APP/PSEN1 transgenic mice.

Tanifum EA, Dasgupta I, Srivastava M, Bhavane RC, Sun L, Berridge J, Pourgarzham H, Kamath R, Espinosa G, Cook SC, Eriksen JL, Annapragada A.

PLoS One. 2012;7(10):e48515. doi: 10.1371/journal.pone.0048515. Epub 2012 Oct 31.

10.

Thioaptamer conjugated liposomes for tumor vasculature targeting.

Mann AP, Bhavane RC, Somasunderam A, Liz Montalvo-Ortiz B, Ghaghada KB, Volk D, Nieves-Alicea R, Suh KS, Ferrari M, Annapragada A, Gorenstein DG, Tanaka T.

Oncotarget. 2011 Apr;2(4):298-304.

11.

Near-infrared imaging method for the in vivo assessment of the biodistribution of nanoporous silicon particles.

Tasciotti E, Godin B, Martinez JO, Chiappini C, Bhavane R, Liu X, Ferrari M.

Mol Imaging. 2011 Feb;10(1):56-68.

12.

In vivo evaluation of safety of nanoporous silicon carriers following single and multiple dose intravenous administrations in mice.

Tanaka T, Godin B, Bhavane R, Nieves-Alicea R, Gu J, Liu X, Chiappini C, Fakhoury JR, Amra S, Ewing A, Li Q, Fidler IJ, Ferrari M.

Int J Pharm. 2010 Dec 15;402(1-2):190-7. doi: 10.1016/j.ijpharm.2010.09.015. Epub 2010 Sep 29.

13.

Tailoring the degradation kinetics of mesoporous silicon structures through PEGylation.

Godin B, Gu J, Serda RE, Bhavane R, Tasciotti E, Chiappini C, Liu X, Tanaka T, Decuzzi P, Ferrari M.

J Biomed Mater Res A. 2010 Sep 15;94(4):1236-43. doi: 10.1002/jbm.a.32807.

14.

Sustained small interfering RNA delivery by mesoporous silicon particles.

Tanaka T, Mangala LS, Vivas-Mejia PE, Nieves-Alicea R, Mann AP, Mora E, Han HD, Shahzad MM, Liu X, Bhavane R, Gu J, Fakhoury JR, Chiappini C, Lu C, Matsuo K, Godin B, Stone RL, Nick AM, Lopez-Berestein G, Sood AK, Ferrari M.

Cancer Res. 2010 May 1;70(9):3687-96. doi: 10.1158/0008-5472.CAN-09-3931.

15.

The association of silicon microparticles with endothelial cells in drug delivery to the vasculature.

Serda RE, Gu J, Bhavane RC, Liu X, Chiappini C, Decuzzi P, Ferrari M.

Biomaterials. 2009 May;30(13):2440-8. doi: 10.1016/j.biomaterials.2009.01.019. Epub 2009 Feb 12.

PMID:
19215978
16.

Mesoporous silicon particles as a multistage delivery system for imaging and therapeutic applications.

Tasciotti E, Liu X, Bhavane R, Plant K, Leonard AD, Price BK, Cheng MM, Decuzzi P, Tour JM, Robertson F, Ferrari M.

Nat Nanotechnol. 2008 Mar;3(3):151-7. doi: 10.1038/nnano.2008.34. Epub 2008 Mar 2.

PMID:
18654487
17.

The effect of shape on the margination dynamics of non-neutrally buoyant particles in two-dimensional shear flows.

Gentile F, Chiappini C, Fine D, Bhavane RC, Peluccio MS, Cheng MM, Liu X, Ferrari M, Decuzzi P.

J Biomech. 2008 Jul 19;41(10):2312-8. doi: 10.1016/j.jbiomech.2008.03.021. Epub 2008 Jun 20.

PMID:
18571181
18.

Glucose-sensing pulmonary delivery of human insulin to the systemic circulation of rats.

Karathanasis E, Bhavane R, Annapragada AV.

Int J Nanomedicine. 2007;2(3):501-13.

19.

Triggered release of ciprofloxacin from nanostructured agglomerated vesicles.

Bhavane R, Karathanasis E, Annapragada AV.

Int J Nanomedicine. 2007;2(3):407-18.

20.

Triggered release of inhaled insulin from the agglomerated vesicles: pharmacodynamic studies in rats.

Karathanasis E, Bhavane R, Annapragada AV.

J Control Release. 2006 Jun 28;113(2):117-27. Epub 2006 Apr 25.

PMID:
16765471
21.

Preparation of in vivo cleavable agglomerated liposomes suitable for modulated pulmonary drug delivery.

Karathanasis E, Ayyagari AL, Bhavane R, Bellamkonda RV, Annapragada AV.

J Control Release. 2005 Mar 2;103(1):159-75. Epub 2004 Dec 7.

PMID:
15710508
22.

Agglomerated vesicle technology: a new class of particles for controlled and modulated pulmonary drug delivery.

Bhavane R, Karathanasis E, Annapragada AV.

J Control Release. 2003 Nov 18;93(1):15-28.

PMID:
14602418

Supplemental Content

Loading ...
Support Center